title: Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children.
abstract: OBJECTIVE
  To evaluate the comparative efficacy and safety of artemether-lumefantrine (AL), artesunate-amodiaquine (ASAQ) and artesunate-amodiaquine-chlorpheniramine (AQC) for the treatment of acute uncomplicated malaria among Southwest Nigerian children.
  
  
  METHODS
  One hundred and sixty children aged 6 months to 14 years with acute uncomplicated malaria were randomized to AL (n = 53), ASAQ (n = 53), or AQC (n = 54). Enrollees were seen daily on days 0-3 and then on days 7, 14, 21, 28 and 42 for clinical and parasitological evaluations. Paired samples of genomic DNA at enrolment and at the time of recurrent parasitaemia were genotyped using nested PCR to distinguish between reinfection and recrudescence. Detailed haematological and biochemical evaluations were carried out in a subset of enrollees on days 0, 7 and 28 as part of a safety evaluation.
  
  
  RESULTS
  Of the 160 children, 144 (90%) completed the study. The mean fever clearance times and parasite clearance times for AL, ASAQ and AQC were comparable (p = 0.94 and p = 0.122, respectively). On day 14, the adequate clinical and parasitological response (ACPR) for AL and AQC was 100% and for ASAQ it was 90% (p = 0.39). The PCR-uncorrected results on days 28 and 42 and the ACPR-corrected results on day 42 were similar for all drugs (p = 0.62 and p = 0.56, respectively). AQC resulted in the best parasite clearance and haematological recovery on day 2 (p = 0.022 and p = 0.018, respectively). Biochemical parameters were not adversely affected by the three artemisinin-based combination therapies (ACTs) and these were well tolerated.
  
  
  CONCLUSIONS
  The three ACTs were efficacious and safe, but AQC resulted in a better haematological recovery on day 2 and higher cure rates throughout the study period.
authors.affiliation: Department of Pharmacology, Therapeutics, University of Ibadan, Ibadan, Nigeria.
authors.forename: C O
authors.initials: CO
authors.lastname: Falade
authors.forename: H O
authors.initials: HO
authors.lastname: Dada-Adegbola
authors.forename: O O
authors.initials: OO
authors.lastname: Ogunkunle
authors.forename: M C
authors.initials: MC
authors.lastname: Oguike
authors.forename: O
authors.initials: O
authors.lastname: Nash
authors.forename: O G
authors.initials: OG
authors.lastname: Ademowo
mesh_terms: D000293:Adolescent; D000655:Amodiaquine / Q000008:administration & dosage / Q000627:therapeutic use*; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D000077549:Artemether; D037621:Artemisinins / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002744:Chlorpheniramine / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005449:Fluorenes / Q000008:administration & dosage / Q000627:therapeutic use*; D018503:Genome, Protozoan; D006801:Humans; D007223:Infant; D000078102:Lumefantrine; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D009549:Nigeria; D016133:Polymerase Chain Reaction
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D004338:Drug Combinations; D004983:Ethanolamines; D005449:Fluorenes; C515299:amodiaquine, artesunate drug combination; D000655:Amodiaquine; D002744:Chlorpheniramine; D000077549:Artemether; D000078102:Lumefantrine
references.citation: Malar J. 2012 Oct 08;11:338
references.pmid: 23043495
references.citation: Trans R Soc Trop Med Hyg. 2005 Jun;99(6):459-67
references.pmid: 15837358
references.citation: Am J Trop Med Hyg. 2006 Nov;75(5):836-42
references.pmid: 17123974
references.citation: Am J Trop Med Hyg. 2011 Nov;85(5):793-804
references.pmid: 22049029
references.citation: Mem Inst Oswaldo Cruz. 2007 Jun;102(3):417-9
references.pmid: 17568949
references.citation: Malar J. 2010 Mar 03;9:68
references.pmid: 20199676
references.citation: Malar J. 2006 May 16;5:43
references.pmid: 16704735
references.citation: Malar J. 2013 Feb 05;12:53
references.pmid: 23384005
references.citation: Malar J. 2012 May 25;11:174
references.pmid: 22631564
references.citation: Trans R Soc Trop Med Hyg. 1999 Jul-Aug;93(4):369-74
references.pmid: 10674079
references.citation: Med Princ Pract. 2008;17(3):197-201
references.pmid: 18408387
references.citation: Am J Trop Med Hyg. 2012 Jul;87(1):23-8
references.pmid: 22764287
references.citation: Malar J. 2008 Nov 27;7:246
references.pmid: 19038036